Display options
Share it on

Ther Adv Endocrinol Metab. 2021 Jan 27;12:2042018821989240. doi: 10.1177/2042018821989240. eCollection 2021.

The effect of specific binding proteins on immunoassay measurements of total and free thyroid hormones and cortisol.

Therapeutic advances in endocrinology and metabolism

Anastasia Gant Kanegusuku, Katherine A Araque, Hung Nguyen, Bin Wei, Saman Hosseini, Steven J Soldin

Affiliations

  1. Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
  2. Endocrinology Pituitary Institute, Pacific Neuroscience Institute, John Wayne Cancer Institute, Santa Monica, CA, USA.
  3. Department of Laboratory Medicine, Clinical Center, National Institutes of Health, 10 Center Drive, Building 10, Bethesda, MD 20892-0001, USA.

PMID: 33552466 PMCID: PMC7844449 DOI: 10.1177/2042018821989240

Abstract

BACKGROUND: Immunoassay (IA) measurements of thyroid hormones have previously given inaccurate results of triiodothyronine (T3), free triiodothyronine (FT3), and free thyroxine (FT4) when concentrations of TBG are low. We evaluate the hypothesis that abnormal concentrations of specific binding proteins (BPs) affect IA measurements and provide results which might misguide the diagnosis and treatment of patients. This study assesses IAs for the measurement of T3, FT3, and cortisol when levels of TBG and CBG are high or low. Comparisons are made between IA and LC-MS/MS.

METHODS: Serum or plasma samples with high (>95th percentile,

RESULTS: When TBG levels are <5th percentile, the differences between the IA and LC-MS/MS results for T3 and FT3 are statistically significant (T3,

CONCLUSION: Abnormal BP concentrations appear to affect the accuracy of IA measurements of T3, FT3, and cortisol. The population of patients with either high or low levels of BPs is significant. Our samples reflect that 65% of women aged between 15 and 49 years are taking oral contraceptives in the US, and thus have elevated levels of BPs. In this group, IA results for cortisol are falsely low. Our samples reflect that patients with protein losing diseases have low BP concentrations. Among a group with renal complications, IA measurements of T3 are overestimated, while those of FT3 are underestimated. Are the Food and Drug Administration and diagnostic companies adequately assessing the accuracy of IA tests?

© The Author(s), 2021.

Keywords: corticosteroid-binding globulin; cortisol; free triiodothyronine; immunoassay; mass spectrometry; thyroxine; thyroxine-binding globulin; triiodothyronine

Conflict of interest statement

Conflict of interest statement: The authors declare that there is no conflict of interest.

References

  1. Clin Endocrinol (Oxf). 2014 Nov;81(5):633-41 - PubMed
  2. Anal Biochem. 2002 Aug 1;307(1):84-91 - PubMed
  3. NCHS Data Brief. 2020 Oct;(388):1-8 - PubMed
  4. Anal Bioanal Chem. 2019 May;411(13):2839-2853 - PubMed
  5. J Clin Endocrinol Metab. 1960 Apr;20:495-514 - PubMed
  6. Clin Biochem. 2007 Dec;40(18):1386-91 - PubMed
  7. J Clin Endocrinol Metab. 1969 Jun;29(6):866-70 - PubMed
  8. Ann Clin Biochem. 2013 Jul;50(Pt 4):345-52 - PubMed
  9. J Clin Endocrinol Metab. 2013 Oct;98(10):3971-3 - PubMed
  10. Ther Adv Endocrinol Metab. 2020 May 27;11:2042018820922688 - PubMed
  11. Eur J Endocrinol. 2021 Feb;184(2):L1-L2 - PubMed
  12. J Mol Endocrinol. 2009 Jul;43(1):19-27 - PubMed
  13. Clin Biochem. 2011 Jan;44(1):89-94 - PubMed
  14. Clin Chem. 1973 Mar;19(3):291-3 - PubMed
  15. J Endocrinol. 2016 Jul;230(1):R13-25 - PubMed
  16. J Steroid Biochem Mol Biol. 2016 Sep;162:110-6 - PubMed
  17. Clin Chim Acta. 2006 Oct;372(1-2):76-82 - PubMed
  18. Endocr Connect. 2018 Dec;7(12):1354-1361 - PubMed
  19. Clin Endocrinol (Oxf). 1987 Aug;27(2):197-203 - PubMed
  20. Ann Clin Biochem. 2011 Sep;48(Pt 5):441-6 - PubMed
  21. Endocr Rev. 1990 Feb;11(1):47-64 - PubMed
  22. Endocr Rev. 2018 Oct 1;39(5):830-850 - PubMed
  23. Clin Chem. 1988 May;34(5):949-52 - PubMed
  24. J Clin Endocrinol Metab. 2005 Nov;90(11):5928-36 - PubMed
  25. Hormones (Athens). 2020 Sep;19(3):425-431 - PubMed
  26. Clin Chem. 2004 Dec;50(12):2345-52 - PubMed
  27. Anesthesiology. 2011 Sep;115(3):568-74 - PubMed
  28. Clin Chim Acta. 2010 Feb;411(3-4):250-2 - PubMed
  29. Clin Biochem. 2020 Aug;82:21-32 - PubMed
  30. Ann Intern Med. 1979 Mar;90(3):335-8 - PubMed
  31. Clin Chem. 2011 Jan;57(1):122-7 - PubMed
  32. Semin Perinatol. 2008 Dec;32(6):403-6 - PubMed
  33. Contraception. 1995 Jun;51(6):341-6 - PubMed
  34. Thyroid. 2007 Apr;17(4):303-11 - PubMed
  35. Horm Metab Res. 2016 Jun;48(6):359-71 - PubMed
  36. Eur J Endocrinol. 2015 Aug;173(2):D1-12 - PubMed
  37. Clin Chem. 1987 Oct;33(10):1946-7 - PubMed
  38. J Clin Endocrinol Metab. 1994 Jul;79(1):76-9 - PubMed
  39. J Clin Endocrinol Metab. 2011 May;96(5):1533-40 - PubMed
  40. Clin Endocrinol (Oxf). 1981 Feb;14(2):193-212 - PubMed
  41. Thyroid. 1999 Jul;9(7):631-5 - PubMed
  42. J Clin Endocrinol Metab. 2004 Feb;89(2):534-43 - PubMed
  43. Clin Chem. 2003 Sep;49(9):1531-5 - PubMed
  44. Thyroid. 2000 Jan;10(1):31-9 - PubMed
  45. JAMA. 2008 Feb 20;299(7):769-77 - PubMed
  46. Clin Chim Acta. 2005 Aug;358(1-2):113-8 - PubMed
  47. Adv Clin Chem. 2013;61:127-52 - PubMed
  48. Clin Chem. 2009 Jul;55(7):1380-8 - PubMed
  49. Clin Chim Acta. 2014 Mar 20;430:121-4 - PubMed
  50. Clin Chem. 2003 Aug;49(8):1250-1 - PubMed
  51. Thyroid. 2004 Dec;14(12):1030-6 - PubMed
  52. Eur J Endocrinol. 2016 Dec;175(6):R255-R263 - PubMed
  53. Clin Biochem. 2014 Sep;47(13-14):1272-8 - PubMed
  54. Clin Biochem. 2016 Aug;49(12):846-9 - PubMed
  55. J Immunol Methods. 2009 Aug 15;347(1-2):3-11 - PubMed
  56. Clin Chem. 2003 Aug;49(8):1381-95 - PubMed

Publication Types